Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


METASTASES TO ABDOMINAL CAVITY side effect

What is METASTASES TO ABDOMINAL CAVITY ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   METASTASES TO ABDOMINAL CAVITY and Recently Reported Side Effects   METASTASES TO ABDOMINAL CAVITY and 15 most Active Side Effect polls   METASTASES TO ABDOMINAL CAVITY and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with METASTASES TO ABDOMINAL CAVITY

ACTONEL  CENESTIN  CISPLATIN  INFLIXIMAB  PROGRAF  QUADRAMET  REMICADE  


Quadramet Side Effects Report #5352524-0
Health Professional from UNITED STATES reported QUADRAMET problem on Dec 06, 2006. Male patient, 78 years of age, was diagnosed with metastases to bone and was treated with QUADRAMET. After drug was administered, patient experienced the following problems/side effects: metastases to abdominal cavity, pain, thrombocytopenia, . QUADRAMET dosage: unknown. During the same period patient was treated with TECHNETIUM TC. Patient died.

Actonel Side Effects Report #5491338-8
ACTONEL problem was reported by a Physician from CANADA on Oct 05, 2007. Female patient, 81 years of age, weighting 95.02 lb, was diagnosed with osteoporosis and was treated with ACTONEL. After drug was administered, patient experienced the following problems/side effects: hypertension, metastases to abdominal cavity, ovarian cancer metastatic, . ACTONEL dosage: 35 MG, 1/WEEK, ORAL. During the same period patient was treated with SYNTHROID, MIACALCIN, PANTOPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Infliximab Side Effects Report #5591191-8
Physician from UNITED STATES reported INFLIXIMAB problem on Jan 09, 2008. Male patient, weighting 161.0 lb, was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, colon cancer, metastases to abdominal cavity, signet-ring cell carcinoma, . INFLIXIMAB dosage: unknown. Patient was hospitalized. Patient died on 10/08/2007.

Prograf Side Effects Report #5419995-2
PROGRAF problem was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 41 years of age, was diagnosed with myasthenia gravis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, malignant neoplasm progression, metastases to abdominal cavity, metastasis, respiratory failure, thymoma malignant recurrent, . PROGRAF dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with MYTELASE, PREDNISOLONE, ATROPINE SULPHATE, GASTERLET, SELBEX, BIOFERMIN. Patient died on 12/29/2005.


Cenestin Side Effects Report #5379575-4
Consumer or non-health professional from JAPAN reported CENESTIN problem on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.

Cenestin Side Effects Report #5379575-4
CENESTIN problem was reported by a Consumer or non-health professional from JAPAN on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.

Remicade Side Effects Report #5749243-5
Physician from UNITED STATES reported REMICADE problem on May 16, 2008. Male patient, weighting 161.0 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, colon cancer, metastases to abdominal cavity, . REMICADE dosage: unknown. Patient was hospitalized. Patient died on 10/08/2007.

Cisplatin Side Effects Report #5289280-0
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Male patient, weighting 137.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: lung consolidation, lung infiltration, metastases to abdominal cavity, metastases to central nervous system, neutropenia, pneumonia, . CISPLATIN dosage: 140 MG. During the same period patient was treated with ETOPOSIDE. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about METASTASES TO ABDOMINAL CAVITY side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about METASTASES TO ABDOMINAL CAVITY